New ISR Phase I Report Shows Rise in Study Complexity and Use of Patient Populations

Informing the drug development and commercialization industry Cary, N.C. – May 15, 2012 – Industry Standard Research (ISR) today announced the release of a new market research report titled “2013 Phase I Study Trends and Market Outlook” providing the pharmaceutical industry and its service providers with new insights into phase-specific trends affecting in-house and outsourced … Continued

ISR’s Risk-based Monitoring Report Offers Industry Peer-based Guidance

Informing the drug development and commercialization industry Cary, N.C. – May 9, 2013 – Industry Standard Research (ISR) released a new market research report today entitled “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing.” The report was developed by surveying industry professionals with direct risk-based monitoring (RBM) experience and provides the pharmaceutical industry and … Continued

ISR CUSTOMERS